# IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia

> **NCT00663234** · PHASE1,PHASE2 · TERMINATED · sponsor: **International Maternal Pediatric Adolescent AIDS Clinical Trials Group** · enrollment: 28 (actual)

## Conditions studied

- HIV Infections
- Hyperlipidemia

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT00663234
- **Lead sponsor:** International Maternal Pediatric Adolescent AIDS Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-08
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** The study was prematurely discontinued due to administrative reasons.
- **Last updated:** 2016-04-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00663234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00663234, "IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00663234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*